Approvals/NMPA/Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅲ)

Approved

化学药品

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅲ)

江苏万高药业股份有限公司🇨🇳 National Medical Products Administration

Approval Id: 8n8cjHzyeY2
Approval Number: 国药准字H20264489
Generic Name: 达格列净二甲双胍缓释片(Ⅲ)
Generic Name En: Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅲ)
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含达格列净5mg（按C₂₁H₂₅ClO₆计）和盐酸二甲双胍1000mg
Reg Date: 2026-05-19
Company Name: 江苏万高药业股份有限公司
Company Address: 江苏省海门经济技术开发区定海路688号
Production Company Name: 江苏万高药业股份有限公司
Production Company Address: 江苏省海门经济技术开发区定海路688号
Company Detail Path: /organization/jiang-su-mo-gao-yao-ye-gu-fen-you-xian-gong-si
Production Company Detail Path: /organization/jiang-su-mo-gao-yao-ye-gu-fen-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

May 19, 2026

Approval ID

8n8cjHzyeY2

Type

化学药品